dwp14012
Showing 1 - 10 of 10
Drug Drug Interaction Trial in Seoul (DWP14012, DWC202201)
Active, not recruiting
- Drug Drug Interaction
- DWP14012
- DWC202201
-
Seoul, Korea, Republic ofSeoul National University Hospital
Apr 2, 2023
Reflux Esophagitis Trial in Guangzhou (DWP14012)
Completed
- Reflux Esophagitis
- DWP14012
-
Guangzhou, Guangdong, ChinaMinhu Chen
Apr 2, 2023
Drug Drug Interaction Trial in Seoul (DWP14012, DWC202202, DWC202203)
Recruiting
- Drug Drug Interaction
- DWP14012
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 6, 2022
Erosive Esophagitis Trial in Seoul (DWP14012)
Recruiting
- Erosive Esophagitis
- DWP14012
-
Seoul, Korea, Republic ofKonkuk University Medical Center
May 12, 2021
Erosive Esophagitis Trial in Seoul (DWP14012)
Unknown status
- Erosive Esophagitis
- DWP14012
-
Seoul, Korea, Republic ofHanyang University Medical Center
Oct 28, 2020
Erosive Gastroesophageal Reflux Disease Trial in Sungdong-gu (DWP14012, Esomeprazole, DWP14012 )
Completed
- Erosive Gastroesophageal Reflux Disease
- DWP14012
- +3 more
-
Sungdong-gu, Seoul, Korea, Republic ofHanyang University Medical Center
Sep 1, 2020
Healthy Male Volunteers Trial in Seoul (DWP14012, Celecoxib, Naproxen)
Unknown status
- Healthy Male Volunteers
- DWP14012
- +3 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jul 27, 2020
Healthy Volunteers Trial in Seoul (DWP14012, Placebo)
Completed
- Healthy Volunteers
- DWP14012
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jun 25, 2019
Healthy Trial in Seoul (DWP14012, Placebo, Esomeprazole)
Completed
- Healthy
- DWP14012
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Apr 23, 2017